Journal Article

DKFZ-2026-00751

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Donor lymphocyte infusions for recurrence of myeloid neoplasms after allogeneic hematopoietic cell transplantation in the era of hypomethylating agents and BCL2 inhibitors.

Jovein, M. M. ; Meyer, T. ; Waterhouse, M. ; Pfeifer, D. ; Duque-Afonso, J. ; Lübbert, M. ; Maas-Bauer, K. ; Wäsch, R. ; Bertz, H. ; Duyster, J. ; Zeiser, R.DKFZ* ; Finke, J. ; Wehr, C.

2026
Springer New York

Keyword(s): Allogeneic stem cell transplantation ; Donor lymphocyte infusions ; Hypomethylating agents ; Myeloid neoplasms ; Relapsed AML ; Venetoclax

---

Contributing Institute(s):

1. DKTK Koordinierungsstelle Freiburg (FR01)

Research Program(s):

1. 899 - ohne Topic (POF4-899) (POF4-899)

Appears in the scientific report 2026

---

Database coverage:
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; DEAL Springer ; DEAL Springer ; Ebsco Academic Search ; Essential Science Indicators ; IF < 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---